We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Craniopharyngioma, a brain tumour affecting children, is difficult to treat. Work within the laboratories of the investigators has identified potential drugs that could turn off tumour growth. These drugs will be tested in patients whose tumours have regrown in a clinical trial.
This research focuses on the development of novel drugs for the treatment of childhood brain tumours.
Examining whether a group of drugs called gliflozins could be used to treat T-ALL
Developing and delivering small molecule drug and immunotherapy combinations for MYC-driven medulloblastoma: Efficacy, evolution and exploitation.
Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma
Enhancing CAR T-cell expansion and prolonged persistence for the effective treatment of paediatric medulloblastoma
ALLTogether1 CSF-FLOW Study
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Investigating the preclinical efficacy of albendazole in paediatric acute myeloid leukaemia
